vs
Side-by-side financial comparison of Organon & Co. (OGN) and Schneider National, Inc. (SNDR). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Schneider National, Inc.). Schneider National, Inc. runs the higher net margin — 1.6% vs -13.6%, a 15.2% gap on every dollar of revenue. On growth, Schneider National, Inc. posted the faster year-over-year revenue change (-1.2% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $48.1M). Over the past eight quarters, Schneider National, Inc.'s revenue compounded faster (-2.8% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Schneider National, Inc. is an American transportation company that provides truckload, intermodal, and logistics services. Schneider's services include regional, long-haul, expedited, dedicated, bulk, intermodal, brokerage, cross-dock logistics, pool point distribution, supply chain management, and port logistics.
OGN vs SNDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.2B |
| Net Profit | $-205.0M | $20.4M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 2.7% |
| Net Margin | -13.6% | 1.6% |
| Revenue YoY | -5.3% | -1.2% |
| Net Profit YoY | -288.1% | -21.8% |
| EPS (diluted) | $-0.78 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B |
| Q1 26 | — | $20.4M | ||
| Q4 25 | $-205.0M | $22.1M | ||
| Q3 25 | $160.0M | $19.4M | ||
| Q2 25 | $145.0M | $36.0M | ||
| Q1 25 | $87.0M | $26.1M | ||
| Q4 24 | $109.0M | $32.6M | ||
| Q3 24 | $359.0M | $30.6M | ||
| Q2 24 | $195.0M | $35.3M |
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
| Q1 26 | — | 2.7% | ||
| Q4 25 | -9.8% | 2.6% | ||
| Q3 25 | 15.2% | 2.4% | ||
| Q2 25 | 14.4% | 3.9% | ||
| Q1 25 | 6.7% | 3.0% | ||
| Q4 24 | 8.1% | 3.2% | ||
| Q3 24 | 13.1% | 3.3% | ||
| Q2 24 | 14.6% | 3.9% |
| Q1 26 | — | 1.6% | ||
| Q4 25 | -13.6% | 1.6% | ||
| Q3 25 | 10.0% | 1.3% | ||
| Q2 25 | 9.1% | 2.5% | ||
| Q1 25 | 5.8% | 1.9% | ||
| Q4 24 | 6.8% | 2.4% | ||
| Q3 24 | 22.7% | 2.3% | ||
| Q2 24 | 12.1% | 2.7% |
| Q1 26 | — | $0.12 | ||
| Q4 25 | $-0.78 | $0.13 | ||
| Q3 25 | $0.61 | $0.11 | ||
| Q2 25 | $0.56 | $0.20 | ||
| Q1 25 | $0.33 | $0.15 | ||
| Q4 24 | $0.42 | $0.19 | ||
| Q3 24 | $1.38 | $0.17 | ||
| Q2 24 | $0.75 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $227.8M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $3.0B |
| Total Assets | $12.9B | $4.9B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $227.8M | ||
| Q4 25 | $574.0M | $41.8M | ||
| Q3 25 | $672.0M | $235.7M | ||
| Q2 25 | $599.0M | $205.1M | ||
| Q1 25 | $547.0M | $154.3M | ||
| Q4 24 | $675.0M | $165.5M | ||
| Q3 24 | $763.0M | $231.6M | ||
| Q2 24 | $704.0M | $157.2M |
| Q1 26 | — | — | ||
| Q4 25 | $8.6B | $390.9M | ||
| Q3 25 | $8.8B | $509.8M | ||
| Q2 25 | $8.9B | $512.7M | ||
| Q1 25 | $9.0B | $565.8M | ||
| Q4 24 | $8.9B | $420.8M | ||
| Q3 24 | $8.7B | $124.7M | ||
| Q2 24 | $8.7B | $125.8M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $752.0M | $3.0B | ||
| Q3 25 | $906.0M | $3.0B | ||
| Q2 25 | $733.0M | $3.0B | ||
| Q1 25 | $542.0M | $3.0B | ||
| Q4 24 | $472.0M | $3.0B | ||
| Q3 24 | $493.0M | $3.0B | ||
| Q2 24 | $144.0M | $3.0B |
| Q1 26 | — | $4.9B | ||
| Q4 25 | $12.9B | $4.8B | ||
| Q3 25 | $13.6B | $5.0B | ||
| Q2 25 | $13.5B | $5.0B | ||
| Q1 25 | $13.2B | $5.0B | ||
| Q4 24 | $13.1B | $4.9B | ||
| Q3 24 | $12.8B | $4.6B | ||
| Q2 24 | $12.2B | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | 11.49× | 0.13× | ||
| Q3 25 | 9.74× | 0.17× | ||
| Q2 25 | 12.14× | 0.17× | ||
| Q1 25 | 16.52× | 0.19× | ||
| Q4 24 | 18.81× | 0.14× | ||
| Q3 24 | 17.75× | 0.04× | ||
| Q2 24 | 60.11× | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $92.9M |
| Free Cash FlowOCF − Capex | $96.0M | $48.1M |
| FCF MarginFCF / Revenue | 6.4% | 3.9% |
| Capex IntensityCapex / Revenue | 3.0% | 3.6% |
| Cash ConversionOCF / Net Profit | — | 4.55× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $356.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $92.9M | ||
| Q4 25 | $141.0M | $186.0M | ||
| Q3 25 | $264.0M | $184.2M | ||
| Q2 25 | $220.0M | $175.5M | ||
| Q1 25 | $75.0M | $91.7M | ||
| Q4 24 | $390.0M | $199.5M | ||
| Q3 24 | $141.0M | $206.4M | ||
| Q2 24 | $332.0M | $182.6M |
| Q1 26 | — | $48.1M | ||
| Q4 25 | $96.0M | $145.5M | ||
| Q3 25 | $218.0M | $56.2M | ||
| Q2 25 | $181.0M | $106.4M | ||
| Q1 25 | $43.0M | $-22.7M | ||
| Q4 24 | $335.0M | $113.6M | ||
| Q3 24 | $99.0M | $98.7M | ||
| Q2 24 | $300.0M | $85.5M |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 6.4% | 10.4% | ||
| Q3 25 | 13.6% | 3.9% | ||
| Q2 25 | 11.4% | 7.5% | ||
| Q1 25 | 2.8% | -1.6% | ||
| Q4 24 | 21.0% | 8.5% | ||
| Q3 24 | 6.3% | 7.5% | ||
| Q2 24 | 18.7% | 6.5% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | 3.0% | 2.9% | ||
| Q3 25 | 2.9% | 8.8% | ||
| Q2 25 | 2.4% | 4.9% | ||
| Q1 25 | 2.1% | 8.2% | ||
| Q4 24 | 3.5% | 6.4% | ||
| Q3 24 | 2.7% | 8.2% | ||
| Q2 24 | 2.0% | 7.4% |
| Q1 26 | — | 4.55× | ||
| Q4 25 | — | 8.42× | ||
| Q3 25 | 1.65× | 9.49× | ||
| Q2 25 | 1.52× | 4.88× | ||
| Q1 25 | 0.86× | 3.51× | ||
| Q4 24 | 3.58× | 6.12× | ||
| Q3 24 | 0.39× | 6.75× | ||
| Q2 24 | 1.70× | 5.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
